Back to results
US 10,479,781 B2Granted
Peptidyl nitril compounds as dipeptidyl peptidase I inhibitors
AssigneeNeuprozyme Therapeutics APS
InventorsConni Lauritzen, John Pedersen
Life of this patent
Estimating the term…
Abstract
The invention relates to compounds of Formula (I) and their use as selective dipeptidyl peptidase I inhibitors, as well as pharmaceutical compositions comprising said compounds, and methods of treatment involving said compounds.
Claims20
A compound of the formula (I)
- wherein n is 0, 1 or 2 and m is 0, 1 or 2;
- such that the sum of m and n is 1, 2, 3 or 4;
- F is fluoro;
- X1 represents
- wherein y represents 0, 1, 2, 3, 4, 5, 6, 7 or 8;
- wherein Z represents O (oxygen);
- when y is 1 or 2, then R1 independently represents deuterium;
- halogen;
- hydroxyl;
- cyano;
- oxo (═0);
- mercapto;
- or C1-3-alkyl;
- which C1-3-alkyl is optionally substituted with at least one substituent selected from halogen, hydroxyl, cyano and mercapto;
- or when y represents 3, 4, 5, 6, 7 or 8, then R1 represents deuterium;
- wherein R2 represents —C3-6-cycloalkyl, —C1-3-alkyl-C3-6-cycloalkyl or —C1-6-alkyl, which —C1-6-alkyl is optionally substituted with at least one substituent selected from hydroxyl, cyano or amino;
- as well as pharmaceutically-acceptable salts, solvates and hydrates thereof.
14 more elements
Dependencies are inferred from the claim text.